Veterinary Stereotactic Radiosurgery Systems - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

The veterinary stereotactic radiosurgery systems market size in 2026 is estimated at USD 4.13 billion, growing from 2025 value of USD 3.71 billion with 2031 projections showing USD 7.07 billion, growing at 11.34% CAGR over 2026-2031. This report is Segmented by Product (Linear Accelerator Systems, and More), Application (Brain Tumours, and More), End User (Veterinary Hospitals, and More), Animal Type (Companion Animals, Equine, and Exotic & Small Mammals), Beam Technology (Photon Beam, and More), and Geography (North America, Europe, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Veterinary Stereotactic Radiosurgery Systems Market Trends and Insights

Growing Companion-Animal Oncology Caseload

One in four dogs develops cancer during its lifetime, making malignancy the principal cause of death in senior pets. Early-detection tools such as IDEXX’s USD 15 Cancer Dx blood test broaden the pool of treatable cases by identifying lymphoma before clinical signs appear. Precision radiosurgery offers sub-millimeter dose targeting that spares healthy tissue, allowing treatment of brain and spinal tumors previously deemed inoperable. Higher caseloads create network effects: as hospitals perform more procedures, outcomes improve and referral confidence rises. This volume-driven model underpins the investment rationale for multi-million-dollar platforms, reinforcing upward demand for equipment and skilled staff.

Expansion of Veterinary Specialty Referral Networks

Corporate groups such as Mars Petcare operate around 3,000 clinics worldwide, many of which funnel complex oncology cases into flagship centers equipped with stereotactic systems. Consolidation aggregates caseloads, improving asset utilization and financing terms for capital purchases. Real-estate investment funds focused on veterinary specialty developments indicate growing outside investor interest, further accelerating infrastructure build-out. Expanded networks shorten client travel distance, reducing a historical barrier to advanced care adoption, and create regional training hubs that enhance workforce capability.

High Capital Expenditure and Operating Costs

A single linear accelerator requires USD 2-4 million in upfront hardware outlay, plus shielding-room construction that can add USD 1-2 million. Annual service contracts typically equal 3.1% of original cost, while mandatory quality-assurance programs add staffing and dosimetry expenses. In low-volume regions, payer mix and caseload rarely deliver breakeven throughput, curbing new-unit placements. Smaller practices increasingly seek joint-venture or corporate ownership structures to share capital risk, which accelerates consolidation but restricts entry for independent clinics.

Other drivers and restraints analyzed in the detailed report include:

• Technological Convergence of Imaging and Therapy
• Increasing Availability of Pet Insurance for High-Cost Procedures
• Limited Supply of Board-Certified Veterinary Radiation Oncologists

Segment Analysis

Linear accelerators held 47.96% of Veterinary stereotactic radiosurgery systems market share in 2025, reflecting their clinical versatility and favorable cost-to-performance ratio. Proton and heavy-ion systems are projected to expand at 13.26% CAGR as compact designs such as IBA’s Proteus ONE lower footprint and shielding requirements. The Veterinary stereotactic radiosurgery systems market sees continuing preference for platforms offering upgradeable software, multi-energy photon beams, and integration with AI-guided imaging. CyberKnife keeps a niche in frameless intracranial work, while gamma-knife adoption remains limited by single-purpose design.

Upgradability drives replacement cycles, encouraging established users to remain in the linear-accelerator ecosystem. Vendors now offer anesthesia-compatible couches and species-specific immobilization devices, reinforcing the modality’s dominance. Proton installations, although few, become regional referral magnets able to command premium case fees, pushing the Veterinary stereotactic radiosurgery systems market toward a stratified service structure.

Brain lesions accounted for 40.98% of total case volume in 2025 as stereotactic radiosurgery offers non-invasive control where craniotomy carries prohibitive morbidity. Head-and-neck disease lines are rising at 13.15% CAGR, driven by improved immobilization techniques and dose-sculpting algorithms that protect adjacent critical structures. The Veterinary stereotactic radiosurgery systems market size attributed to spinal tumors is also increasing as motion-management tools mature.

Evidence demonstrates median canine survival exceeding two years following stereotactic treatment of intracranial tumors, far outperforming traditional fractionated protocols. Expanding indication sets broaden utilization, enhancing return on equipment investment and stabilizing workflow for treatment teams.

Complete Report Scope:

• By Product
  • Linear Accelerator Systems
  • CyberKnife Systems
  • Gamma Knife Systems
  • Proton / Heavy-ion Systems
• By Application
  • Brain Tumours
  • Spinal Tumours
  • Head & Neck Tumours
  • Soft-Tissue / Other Tumours
• By End User
  • Veterinary Hospitals (≥10 oncology beds)
  • Veterinary Specialty Clinics (< 10 oncology beds)
  • Research & Academic Institutions
• By Animal Type
  • Companion Animals (Canine, Feline)
  • Equine
  • Exotic & Small Mammals
• By Beam Technology
  • Photon Beam
  • Gamma Photon
  • Proton / Heavy-ion
• Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America retained a 38.22% revenue share in 2025, underpinned by mature insurance adoption and the presence of large multi-hospital networks able to amortize USD-multimillion equipment costs. Early adoption of technologies such as CyberKnife validates the clinical model and supplies training pipelines for new specialists. Market expansion remains steady as pet-owner awareness rises and early-screening tests feed higher case volumes.

Europe shows mid-single-digit growth buoyed by robust veterinary school infrastructure and harmonized device regulations. Facilities like Dick White Referrals invested GBP 15 million to triple capacity, integrating 0.35-T MRI simulators to streamline adaptive planning. Regional insurers cap out-of-pocket costs, further supporting uptake.

Asia-Pacific, posting 12.28% CAGR, benefits from rising disposable income and evolving regulations that now accept CE-marked radiotherapy systems with limited local testing, accelerating import pathways. China’s urban middle class increasingly views advanced pet care as a lifestyle marker, yet specialist shortages remain acute. Joint-training programs with US and EU colleges are underway to build regional expertise.

South America, the Middle East, and Africa remain nascent markets where import duties and currency volatility hinder equipment procurement. Pilot installations in Mexico signal gradual improvement as governments prioritize companion-animal welfare, but widespread adoption awaits stronger insurance penetration and workforce development.

List of Companies Covered in this Report:

• Accuray
• Varian Medical Systems
• Elekta
• ViewRay Inc.
• Siemens Healthineers
• RefleXion Medical
• ZAP Surgical Systems
• Best Theratronics Ltd.
• Xstrahl Ltd.
• Avante Health Solutions
• Canon
• United Imaging Healthcare
• Brain Lab
• PetCure Oncology
• Nanovi
• Medtronic
• IntraOp Medical
• VCA Animal Hospitals

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support